Yu Wen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Wen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Guoqing Ouyang
Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China
2 shared publicationsHe Huang
Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, 410078, PR China
2 shared publicationsLi Xiong
Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China
2 shared publicationsLiangwu Lin
State Key Laboratory for Powder Metallurgy, Central South University, Changsha Hunan, 410083, PR China
2 shared publicationsXiongying Miao
Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China
2 shared publicationsZhipeng Liu
Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China
2 shared publications
Latest Publications
- Open Access
- 24 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-11
Investigation of Copper Cysteamine Nanoparticles as a New Type of Radiosensitiers for Colorectal Carcinoma Treatment
Copper Cysteamine (Cu-Cy) is a new photosensitizer and a novel radiosensitizer that can be activated by light, X-ray and microwave to produce singlet oxygen for cancer treatment. However, the killing mechanism of Cu-Cy nanoparticles on cancer cells is not clear yet and Cu-Cy nanoparticles as novel radiosensitizers have never been tested on colorectal cancers. Here, for the first time, we investigate the treatment efficiency of Cu-Cy nanoparticles on SW620 colorectal cells and elucidate the underlying mechanisms of the effects. The results show that X-ray activated Cu-Cy nanoparticles may kill SW620 cancerscells is in a dose-dependent manner. The JC-1 staining shows the mitochondrial membrane potential is decreased after the treatment. The observations confirm that Cu–Cy nanoparticles may improve X-ray radiotherapy on cancer treatment and X-ray activated Cu-Cy nanoparticles can be efficiently destroy colorectal cancer cells by inducing apoptosis as well as autophagy. As a new type of radiosensitizers and photosensitizers, Cu-Cy nanoparticles have a good potential for colorectal cancer treatment and the discovery of autophagy induced by X-ray irradiated Cu-Cy nanoparticles sheds a good insight to the mechanism of Cu-Cy for cancer treatment as a new radiosensitizers.
- 24 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-11
Open AccessInvestigation of Copper Cysteamine Nanoparticles as a New Type of Radiosensitiers for Colorectal Carcinoma Treatment
Copper Cysteamine (Cu-Cy) is a new photosensitizer and a novel radiosensitizer that can be activated by light, X-ray and microwave to produce singlet oxygen for cancer treatment. However, the killing mechanism of Cu-Cy nanoparticles on cancer cells is not clear yet and Cu-Cy nanoparticles as novel radiosensitizers have never been tested on colorectal cancers. Here, for the first time, we investigate the treatment efficiency of Cu-Cy nanoparticles on SW620 colorectal cells and elucidate the underlying mechanisms of the effects. The results show that X-ray activated Cu-Cy nanoparticles may kill SW620 cancerscells is in a dose-dependent manner. The JC-1 staining shows the mitochondrial membrane potential is decreased after the treatment. The observations confirm that Cu–Cy nanoparticles may improve X-ray radiotherapy on cancer treatment and X-ray activated Cu-Cy nanoparticles can be efficiently destroy colorectal cancer cells by inducing apoptosis as well as autophagy. As a new type of radiosensitizers and photosensitizers, Cu-Cy nanoparticles have a good potential for colorectal cancer treatment and the discovery of autophagy induced by X-ray irradiated Cu-Cy nanoparticles sheds a good insight to the mechanism of Cu-Cy for cancer treatment as a new radiosensitizers.
- Open Access
- 23 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (4) , 6419-6432
Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells
Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells
- 23 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (4) , 6419-6432
Open AccessAutophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells
Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells